Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.83 USD | +5.79% | +10.21% | +66.29% |
01:19pm | Baird Starts Spyre Therapeutics With Outperform Rating, $50 Price Target | MT |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.29% | 1.36B | |
-1.88% | 104B | |
+6.53% | 97.47B | |
+5.71% | 22.25B | |
-12.62% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.15% | 16.36B | |
+7.03% | 14.39B | |
+36.57% | 12.37B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares